Company Search:
Advanced Search
Sponsored Links
Shandong Lukang Pharmaceutical Company Snapshot
Shandong Lukang Pharmaceutical operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shandong Lukang Pharmaceutical with three other companies in this sector in China: ChangChun High New Technology Industries (2015 sales of 2.37 billion Chinese Renmimbi [US$345.62 million] of which 79% was Medication), Shenzhen Hepalink Pharmaceutical Company Limited (2.29 billion Chinese Renmimbi [US$333.23 million] of which 100% was Pharmaceutical Manufacturing), and Shanxi Zhendong Pharmaceutical Co Ltd (2.26 billion Chinese Renmimbi [US$329.20 million] of which 95% was Medicine Manufacture and Sale).

Sales Analysis. During the year ended December of 2015, sales at Shandong Lukang Pharmaceutical were 2.41 billion Chinese Renmimbi (US$350.64 million). This is an increase of 4.2% versus 2014, when the company's sales were 2.31 billion Chinese Renmimbi. The sales level in 2015 was fairly close to the level five years ago: in 2010, Shandong Lukang Pharmaceutical had sales of 2.20 billion Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Shandong Lukang Pharmaceutical
  Stock Performance Chart for Shandong Lukang Pharmaceutical
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 10.46
(Figures in Chinese Renmimbi)
1 Week 4.2%   13 Weeks 13.1%  
4 Weeks 0.4%   52 Weeks 0.0%  
Shandong Lukang Pharmaceutical Key Data:
  Ticker: 600789 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2015 Sales 2,409,266,237
(Year Ending Jan 2016).
Employees: 5,940
  Currency: Chinese Renmimbi Market Cap: 6,083,279,469
  Fiscal Yr Ends: December Shares Outstanding: 581,575,475
  Share Type: A Gu Closely Held Shares: 190,303,594
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.